What we do

We are a science-led global healthcare company. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare.

We have a significant global presence with commercial operations in more than 150 countries, a network of 89 manufacturing sites, and large R&D centres in the UK, USA, Belgium and China.

Pharmaceuticals

Our Pharmaceuticals business develops and makes medicines to treat a broad range of acute and chronic diseases.

In New Zealand, our pharmaceutical products include treatments for asthma, breast cancer, depression, diabetes, Parkinson’s disease, HIV/AIDS, and epilepsy among many others.

Vaccines

Our Vaccines business is one of the largest in the world, producing paediatric and adult vaccines against a range of infectious diseases.

GSK’s portfolio of vaccines in New Zealand helps prevent illnesses such as measles, mumps, rubella, whooping cough, influenza and bacterial meningitis.

Consumer Healthcare

Our Consumer Healthcare business develops and markets a range of over-the-counter consumer healthcare products across the key areas of oral health, pain relief, nutritional/gastrointestinal, respiratory and skin health.

Well-known GSK consumer healthcare brands in New Zealand include Sensodyne, Voltaren, Panadol, Macleans, Flixonase and Zovirax.